Skip to main content

Table 1 Demographic, clinical and bronchoscopic characteristics of the enrolled cohort

From: Bronchoscopy to assess patients with hemoptysis: which is the optimal timing?

Total cohort, n (%)

486 (100)

Age (years), median (IQR)

67 (53–76)

Males, n (%)

336/486 (69.2%)

Hemoptysis severity, n (%)

Mild

330/486 (67.9%)

Moderate

144/486 (29.6%)

Severe

12/486 (2.4%)

Life-threatening hemoptysis, n (%)

20/486 (4.1%)

Flexible bronchoscopies, n (%)

471/486 (96.9%)

Flexible bronchoscopies during endotracheal intubation, n (%)

2/486 (0.4%)

Rigid bronchoscopies, n (%)

13/486 (2.7%)

Therapeutic bronchoscopies, n (%)

99/486 (20.4%)